Clinical Trials Directory

Trials / Completed

CompletedNCT04094103

Strawberry Consumption in Overweight and Obese Individuals

Integrated Cardiovascular and Metabolic Effects of Strawberry Consumption in Overweight and Obese Individuals

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
48 (actual)
Sponsor
Carl Ade, M.S., Ph.D. · Academic / Other
Sex
All
Age
35 Years – 75 Years
Healthy volunteers
Accepted

Summary

Our proposal represents an integrated approach to determining the cardiovascular and metabolic effects of strawberry consumption in adults who have high risk for cardiometabolic disease.

Detailed description

The current proposal aims to fill some of these important research gaps with regard the dose and time-course of strawberry consumption in a population where dietary intervention may of particular benefit for both primary and secondary prevention of cardiovascular and metabolic disease. Participants will participate in a double blind, placebo-controlled, randomized crossover trial. Following a 10-day run-in where no berries are consumed, participants will be randomized via Latin-square design, to three different daily strawberry powder conditions for 4-weeks at a time, with a 7 day washout between conditions.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTActive strawberry powderParticipants will drink a strawberry beverage with active ingredients once a day during the 4-week intervention period.
DIETARY_SUPPLEMENTPlacebo strawberry powderParticipants will drink a strawberry placebo beverage once a day during the 4-week intervention period.
DIETARY_SUPPLEMENTMixed strawberry powderParticipants will drink a mixed strawberry beverage with active ingredients and placebo once a day during the 4-week intervention period.

Timeline

Start date
2019-10-01
Primary completion
2023-10-27
Completion
2023-10-27
First posted
2019-09-18
Last updated
2025-09-02

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04094103. Inclusion in this directory is not an endorsement.